Shaikh N, Raut S K, Bedekar S S, Phadke M A, Banerjee K
National Institute of Virology, Pune.
Indian Pediatr. 1992 Jul;29(7):883-7.
Five hundred and twenty seven children between 7 months and 2 years of age were vaccinated with measles vaccine manufactured by the Serum Institute of India. The sero-conversion rate in children who had no antibodies previous to vaccination was 98.4% as tested in HI. Ninety per cent of children who had pre-vaccination measles antibodies showed a two-fold or more rise in HI antibodies. The side reactions of the vaccine were negligible.
527名7个月至2岁的儿童接种了印度血清研究所生产的麻疹疫苗。接种前无抗体的儿童中，血凝抑制试验（HI）检测的血清转化率为98.4%。接种前有麻疹抗体的儿童中，90%的儿童HI抗体升高两倍或更多。该疫苗的副作用可忽略不计。
